Cyclooxygenase-2 and chemoprevention of breast cancer (Q35586832)

9 August 2017

1 reference

title

Cyclooxygenase-2 and chemoprevention of breast cancer (English)

1 reference

9 August 2017

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

3 April 2024

author name string

Davies GL

1

1 reference

9 August 2017

G. L S. Davies

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14623549

3 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14623549

3 April 2024

publication date

1 September 2003

1 reference

full work available at URL

9 August 2017

https://api.elsevier.com/content/article/PII:S0960076003003790?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

https://api.elsevier.com/content/article/PII:S0960076003003790?httpAccept=text/plain

3 April 2024

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

The Journal of Steroid Biochemistry and Molecular Biology

3 April 2024

published in

1 reference

9 August 2017

86

1 reference

9 August 2017

3-5

1 reference

9 August 2017

495-499

1 reference

Prospective study of regular aspirin use and the risk of breast cancer

9 August 2017

2

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Nonsteroidal antiinflammatory drugs and breast cancer

3 April 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Cyclooxygenase 2 induction: molecular mechanism and pathophysiologic roles

3 April 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse

3 April 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene

3 April 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Elevated cyclooxygenase-2 levels in Min mouse adenomas

3 April 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

3 April 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens

3 April 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

The production of prostanoids in human cancers, and their implications for tumor progression

3 April 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators

3 April 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas

3 April 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor

3 April 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

3 April 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer

3 April 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors

3 April 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

3 April 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer

3 April 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey

3 April 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

A prospective study of endogenous hormones and breast cancer

3 April 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione

3 April 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Aromatase activity in adipose tissue from breast quadrants: a link with tumour site.

3 April 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction

3 April 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

A CRE-like sequence that binds CREB and contributes to cAMP-dependent regulation of the proximal promoter of the human aromatase P450 (CYP19) gene

3 April 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

3 April 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

Risk of cardiovascular events associated with selective COX-2 inhibitors

3 April 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JSBMB.2003.07.004

3 April 2024

Identifiers

1 reference

9 August 2017

1 reference